penicillins Pharmacology Hand made notes

Download now Report

Download PDF: Penicillins Pharmacology (Handmade Notes)

Access a valuable resource on Penicillins Pharmacology in the form of handmade notes, available as a downloadable PDF. These notes are ideal for students of medicine, pharmacy, and nursing looking for a clear and concise overview of this important class of beta-lactam antibiotics.

Download these detailed handmade notes for offline study or view the document online. Understand the core pharmacology of penicillins, including their mechanism of action, classification, antibacterial spectrum, pharmacokinetics, clinical uses, and mechanisms of bacterial resistance.

Keywords for this resource:

Download PDF, Penicillins Pharmacology, Handmade Notes, Beta-Lactam Antibiotics, Amoxicillin, Penicillin G, Mechanism of Action, Antibacterial Spectrum, Antibiotic Resistance, Pharmacology Study Material, Free Medical Notes, Slides By DuloMix.

Pharmacology of Penicillins: A Cornerstone of Antibacterial Therapy

Penicillins, discovered by Alexander Fleming in 1928, were the first true antibiotics and revolutionized the treatment of bacterial infections. They belong to the β-lactam class of antibiotics, characterized by the presence of a β-lactam ring in their chemical structure, which is essential for their antibacterial activity. Understanding the pharmacology of penicillins—their mechanism of action, classification, spectrum of activity, pharmacokinetics, adverse effects, and mechanisms of resistance—is fundamental for their appropriate clinical use.

Mechanism of Action

Penicillins are bactericidal agents that interfere with the synthesis of the bacterial cell wall. Specifically, they inhibit the final step in peptidoglycan synthesis, which is cross-linking of peptidoglycan strands. This process is catalyzed by enzymes known as penicillin-binding proteins (PBPs), which are transpeptidases.

1. Penicillins bind covalently to the active site of PBPs.
2. This binding inactivates the PBPs, preventing them from cross-linking the peptidoglycan chains.
3. The weakened cell wall cannot withstand the internal osmotic pressure of the bacterium, leading to cell lysis and death, particularly in growing bacteria.

The integrity of the β-lactam ring is crucial for this activity. If the ring is cleaved (e.g., by bacterial β-lactamase enzymes), the penicillin loses its antibacterial efficacy.

Classification and Spectrum of Activity

Penicillins are classified based on their chemical structure and antibacterial spectrum:

1. Natural Penicillins:

• Examples: Penicillin G (benzylpenicillin - typically given parenterally), Penicillin V (phenoxymethylpenicillin - acid-stable, given orally).
• Spectrum: Primarily active against Gram-positive cocci (e.g., non-β-lactamase producing Staphylococcus, Streptococcus pyogenes, Streptococcus pneumoniae), Gram-positive rods (e.g., Clostridium spp., Bacillus anthracis), Gram-negative cocci (e.g., Neisseria meningitidis, Neisseria gonorrhoeae - though resistance is common), and spirochetes (e.g., Treponema pallidum - syphilis). They have limited activity against Gram-negative rods because they cannot effectively penetrate their outer membrane. Susceptible to hydrolysis by β-lactamases.

2. Anti-staphylococcal Penicillins (Penicillinase-Resistant Penicillins):

• Examples: Methicillin (prototype, rarely used due to nephrotoxicity), Nafcillin (IV), Oxacillin (IV), Cloxacillin (PO/IV), Dicloxacillin (PO).
• Spectrum: Specifically designed to be resistant to staphylococcal β-lactamases (penicillinases). Their primary use is against β-lactamase-producing Staphylococcus aureus (MSSA - Methicillin-Susceptible S. aureus). They are less active than Penicillin G against other Penicillin G-susceptible organisms. Ineffective against MRSA (Methicillin-Resistant S. aureus), which has altered PBPs.

3. Aminopenicillins (Extended-Spectrum Penicillins):

• Examples: Ampicillin (PO/IV), Amoxicillin (PO).
• Spectrum: Retain activity against organisms susceptible to Penicillin G but have enhanced activity against some Gram-negative rods due to better penetration of the outer membrane. These include Haemophilus influenzae, Escherichia coli, Proteus mirabilis, Salmonella, and Shigella spp. (often referred to by the mnemonic HENPEcK or HHELPSS). They are, however, susceptible to β-lactamase hydrolysis. Often combined with a β-lactamase inhibitor (e.g., amoxicillin/clavulanate, ampicillin/sulbactam) to extend their spectrum against β-lactamase producing strains.

4. Anti-pseudomonal Penicillins (Extended-Spectrum Penicillins):

These have even broader activity against Gram-negative bacteria, including Pseudomonas aeruginosa.

• Carboxypenicillins: Ticarcillin (older, often combined with clavulanate).
• Ureidopenicillins: Piperacillin (most potent, usually combined with tazobactam - a β-lactamase inhibitor).
• Spectrum: In addition to the aminopenicillin spectrum, they cover Pseudomonas aeruginosa, many Enterobacter spp., Klebsiella spp. (piperacillin/tazobactam), and other difficult-to-treat Gram-negative organisms. They are susceptible to β-lactamases unless combined with an inhibitor.

Pharmacokinetics (General Properties)

• Absorption: Varies. Penicillin V, amoxicillin, dicloxacillin are well-absorbed orally. Penicillin G is acid-labile and given parenterally. Amoxicillin absorption is not significantly affected by food, unlike ampicillin.
• Distribution: Widely distributed into body fluids and tissues. Penetration into CSF is generally poor unless meninges are inflamed. Most cross the placenta.
• Protein Binding: Varies among penicillins (e.g., Penicillin G ~60%, Oxacillin ~90%, Amoxicillin ~20%).
• Excretion: Primarily renal, through glomerular filtration and active tubular secretion. Probenecid can block tubular secretion, prolonging the half-life of penicillins. Dose adjustment is needed in renal impairment for most penicillins. Nafcillin is an exception, being primarily eliminated via biliary excretion.

Adverse Effects

• Hypersensitivity Reactions: Most common adverse effect, ranging from skin rashes (maculopapular rash, urticaria) to angioedema, serum sickness, and anaphylaxis (rare but life-threatening). Cross-allergenicity among different penicillins is high.
• Gastrointestinal Disturbances: Nausea, vomiting, diarrhea (especially with oral aminopenicillins, can be due to disruption of gut flora leading to Clostridioides difficile infection).
• Hematologic Effects (Rare): Hemolytic anemia, neutropenia, thrombocytopenia (usually with high doses and prolonged therapy).
• Neurologic Toxicity (Rare): Seizures can occur with very high doses or in patients with renal failure, due to accumulation.
• Interstitial Nephritis: Particularly associated with methicillin, but can occur with other penicillins.
• Jarisch-Herxheimer Reaction: When treating spirochetal infections like syphilis, rapid lysis of bacteria can release endotoxins, causing fever, chills, headache, and myalgia.

Mechanisms of Bacterial Resistance

1. β-Lactamase Production: Most common mechanism. Bacteria produce enzymes (β-lactamases or penicillinases) that hydrolyze the β-lactam ring, inactivating the antibiotic. This is overcome by using penicillinase-resistant penicillins or combining penicillins with β-lactamase inhibitors (e.g., clavulanic acid, sulbactam, tazobactam).
2. Modification of Target PBPs: Alterations in the structure of PBPs reduce their affinity for β-lactam antibiotics. This is the mechanism of resistance in MRSA (mecA gene encoding PBP2a) and penicillin-resistant Streptococcus pneumoniae.
3. Impaired Penetration: In Gram-negative bacteria, changes in porin channels in the outer membrane can reduce the entry of penicillins into the periplasmic space where PBPs are located.
4. Efflux Pumps: Some bacteria can actively pump the antibiotic out of the cell.

Conclusion

Penicillins remain a vital class of antibiotics for treating a wide range of bacterial infections. Their efficacy, relative safety (for non-allergic individuals), and varied spectrum make them indispensable. However, the ever-present challenge of bacterial resistance necessitates their judicious use, understanding of local resistance patterns, and continued research into new antibacterial strategies.

Info!
If you are the copyright owner of this document and want to report it, please visit the copyright infringement notice page to submit a report.